Treatments | Concentration (ppm) | CAT activity (U mg−1 protein) | POX activity (U mg−1 protein) | H2O2 concentration (µmol g−1 FW) |
---|---|---|---|---|
Control | – | 24.77 ± 0.29l | 0.044 ± 0.0003g | 4.22 ± 0.09e |
bSiO2 | 1 | 27.74 ± 0.30k | 0.045 ± 0.0004fg | 4.36 ± 0.04de |
5 | 29.82 ± 1.58ij | 0.046 ± 0.0010fg | 4.36 ± 0.07de | |
10 | 30.38 ± 0.37g−j | 0.049 ± 0.0004d−f | 4.24 ± 0.05e | |
25 | 31.61 ± 0.18d−g | 0.050 ± 0.0007de | 4.42 ± 0.03de | |
50 | 31.20 ± 0.79f−i | 0.050 ± 0.0009de | 4.63 ± 0.01a−c | |
100 | 30.24 ± 0.24g−j | 0.052 ± 0.0005cd | 4.70 ± 0.02a | |
nSiO2 (I) | 1 | 29.88 ± 0.15ij | 0.047 ± 0.0006e−g | 3.1 ± 0.04i |
5 | 31.45 ± 0.49e−h | 0.056 ± 0.0039a | 3.46 ± 0.04 h | |
10 | 32.41 ± 0.54c−f | 0.058 ± 0.0007a | 3.68 ± 0.10 fg | |
25 | 33.09 ± 0.25cd | 0.057 ± 0.0030a | 3.87 ± 0.18f | |
50 | 32.81 ± 0.46c−e | 0.056 ± 0.0005ab | 4.53 ± 0.06b−d | |
100 | 31.72 ± 0.39d−g | 0.055 ± 0.0004a−c | 4.69 ± 0.02ab | |
nSiO2 (II) | 1 | 29.29 ± 0.37j | 0.052 ± 0.0012b−d | 3.50 ± 0.05gh |
5 | 29.93 ± 0.37h−j | 0.055 ± 0.0004ab | 3.62 ± 0.06gh | |
10 | 36.15 ± 0.29a | 0.057 ± 0.0003a | 3.67 ± 0.10 fg | |
25 | 34.66 ± 0.21ab | 0.057 ± 0.0003a | 4.48 ± 0.04 cd | |
50 | 33.25 ± 0.23bc | 0.056 ± 0.0003a | 4.55 ± 0.04b−d | |
100 | 32.90 ± 0.65c−e | 0.051 ± 0.0005d | 4.65 ± 0.04a−c |